Open now
 08045132036
DRUGCONSULTANTS
https://www.acplgroupindia.in
91

Chat with us on WhatsApp

×

Search

  1. Home
  2. Search results for "patient subject details"
Home / Search results for "patient subject details"

10.As provided in the rules, surrogate marker should be considered as an interim data poin...

2023-10-28T05:49:20

View more

ND & CT rules recognize the consideration of surrogate endpoints for approval of new drugs...

2023-10-26T11:12:10

View more

ND & CT rules recognize the consideration of surrogate endpoints for approval of new drugs...

2023-10-25T05:12:59

View more

The Drugs & Cosmetics Act, 1940 and rules 1945 have entrusted various responsibilities to ...

2023-12-29T05:09:45

View more

Sugam builds a comprehensive database of the various permissions and licenses issued by S...

2023-12-29T05:07:19

View more

6. However, accelerated approval should be used for a drug that represent significant adva...

2023-10-28T05:47:30

View more

INTRODUCTION 1. A number of communicable as well as non-communicable diseases place heavy ...

2023-10-28T05:39:00

View more

After the NDA is accepted the various section of the application should undergo concurrent...

2023-10-26T11:13:04

View more

INTRODUCTION 1. A number of communicable as well as non-communicable diseases place heavy ...

2023-10-26T05:36:08

View more

Subscribe for latest offers and updates.

we hate spam too